Relapsed/Refractory Glioma Clinical Trials in Zhengzhou, Henan

A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma